ARCHIVES

July issue of Business & Regulatory report (8 additional pages) included.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Amgen, J&J Defend ESA Indications.

March 21, 2008

NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.

November 28, 2003

Sharon Murphy To Head New Research Center in San Antonio

August 2, 2002

Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less

August 2, 1985

Cooperative Groups: PCPT Enrollment Complete, Three Years To The Day rial Began

December 13, 1996